# 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension

> **NCT00624052** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 838 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** fixed-dose combination of telmisartan 40mg+amlodipine 10mg
- **DRUG:** fixed-dose combination of telmisartan 80mg+amlodipine10mg

## Key facts

- **NCT ID:** NCT00624052
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-06
- **Final completion:** —
- **Target enrollment:** 838 (ACTUAL)
- **Last updated:** 2014-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00624052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00624052, "26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00624052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*